Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Running to silver...post r/s in $'s with Nasdaq uplisting. Genius move by mgt to declare r/s before deal. Soon we'll see filings, signatures and the 1.3B in action
Get ready for the Big Squeeze!!! $$$'s
Solid News! Volume before price..this news and the April 1 UJ energy/gas installation will send this north....big news will be the Madagascar MOU and it looks like they have the framework in place and added a manufacturer today to scale their revolutionary fuel cells to MW sizes. Everything is looking up!
Potential acquisitions??
It seems that the 3 or 4 potential competitors mentioned above evolved from the herbal and supplement territory and are trying to “upgrade” their products to the status of Botanical Therapeutics® (the trademark owned by Herborium).
Because the herbal supplement industry is highly fragmented, Herborium’s bid for leadership in the sector may include strategic mergers and acquisitions, depending on appropriate financial resources.
New Products...already made!! Being packaged!!
The first products to be launched after AcnEase® are Lasting Pleasure® for Women, Last- ing Power® for Men and Lasting Energy®. Together, this represents over $15 Billion in market opportunity in the wellness sector. All three products are herbal proprietary formulations with validated efficacy and safety profiles. The formula- tion is complete and the manufacturing of the first batch of these products took place in August 2014. They are presently in the process of being packaged and the marketing and branding strategies are being finalized.
Stock has never been this low....in fact in the past three years this stock has run to dollars....so your story is not plausible.
Those buying shares now will be very happy $$$$$$
The Dragon awakens!! Let's see the MOU and UJ gas line. Dollars coming #PowerAfrica
Drastic amount of covering going on...take a look at this http://otcshortreport.com/?index=IFCR&action=view
Every short is exiting....over 60% of volume was short and we all know you can't short a .0001 stock for a profit so the volume was shorts exiting so they don't get squeezed to a pulp as IFCR skyrockets. Let's see the news!!
It's over the 48 hour limit to sticky, we'll have news to sticky soon
I wanted to add that earlier when I updated the Ibox but could not figure it out and used the text instead. Apply to be a moderator, you can add it and/or sticky it as a post
Good Add
Overall, I counted at most, 5,633,339 in debt which is reasonable for a company that had $25M in revs. Also discussed in the 8k were three lawsuits,
First, a suit against Robbins Consulting which IFCR filed in March 2016, pursuing $979,878 in damages
A suit against Smith Systems Transport in May 2016, which IFCR is aggressively pursuing and "confident it will prevail.
And a fraudulent suit filed May 2016, against IFCR from a defunct subsidiary which has already been financially allocated for.
Profits from the lawsuits will help to extinguish the debt. The suit against Robbins could yield roughly a million depending upon how IFCR settles and the suit against Smith should be well over a million.
The suits were filed over a year or roughly a year ago, they should be finished or close to completion.
Good to know. I sent the management an email and will reply with what they say. However, the PR may beat me to it.
There are an endless amount of stocks on the OTC, they'd be on the phone the whole day. I've used mm signals to profit handsomely, particularly when I see 911 or a 500 shows at the end of the day.
MMs love channels such as .0001-.0002 and anything in the 9-11 range. They use these channels to flip and .0001-.0002 is a favorite as it is a nice 100% gain. However, when a stock has momentum the MMs let it rip since they can sell that same .0001 share at .001 for 1000%
All in all, this stock has been held down and is coiled like a spring...with news this is gapped up
Ifcr had a falling out with their subs and sued them. David the past CEO gave up his title (still on board) so as to personally sue smith trucking.
This company has been a turnaround project since 2012 when a truck belonging to a sub was involved in an accident and sued. The company has been getting back on its feet since then.
Stock was .15 in 2011 with run rate revs of 20M and the debt was 19M.
Today the stock is .0001 and last I checked debt was somewhere between 4-6M I believe and revs around 15M but with this quiet period it's anyone's guess what Oz is doing behind the curtain.
From my discussions with mgt, a new CEO with Nasdaq exp was being offered as well as new subs (one was in Tampa).
Overall, no r/s coming and so this can only go up
Throw in news about new subs, new CEO, lower debt, litigation settlement (we should get a few mill from smith) and this stock is a dime.
Take a look at MM trade signals. To be brief 100, 200, and 300 mean I need more shares with 400 indicating keep it trading sideways. 500 is gap it (in the direction of the trade) and 911 is news. MMs have alerts for these types of trades set on their scanners that way they aren't short squeezed.
5000 is potentially a derivative of 500.
This stock is about to show its hand, hold tight.
Dave and Hoffman have over a 100M shares each. Therefore the float is tighter than most think. Also, neither is selling period. They have worked for years turning this company around, and they've finally done it! Now comes their big payday. The higher the better for them (and us clearly) and so they have a vested interest in hiking the price....plus the stock will also be more attractive to future subsidiaries at the higher price...hence the mega promo happening.
For the long term investors like myself, Patience has finally paid
Read the full report. Float is tiny here, those 200M shares are not headed to the market. 700k in debt will be gone in a flash, the potential here is in the millions. Revenue will come flooding in. If you are a weak hand get out, investors will pig pile for your shares.
Those 200M shares were for the CEO...this is as good as it gets. He has 17% of the o/s (as of last report) that means that this is even thinner than we think!!
Great find!!
The future for this company and its shareholders is looking brighter and brighter, glad you will be joining us for the ride $$$
GDGI is maxed out, float is locked!
Fins from yesterday showed o/s at 2,324,942,380 and a/s is 3B
Breakout is imminent. 500M traded by lunch all this action at 2s, no 1s!
Only 700k in debt and tons of news and POTential
The MJ run is on! PVSP is due for fins, a PR and a run out of the subs . This was a super thin stock last march and history has history of repeating itself. Lock and Load
This stock has a ton of news and momentum in that regard and has been on tv, in Cosmo, and have had uptick do a promo. Still, not being able to see the news on Ihub without pulling up the Ibox is disconcerting since many use mobile. I'll contact Ihub and see if they can change this.
200 and 50 SMAs crossed today. I said in December this would drop below a penny so they could get the stop-loss investors out. They've been shaking hands for awhile now and the epic run last year started in mid-March. Time to get excited, a few PRs and I'll see you at a dollar. Mark it!!
Vroom vroom
Only profitable trip 1 on OTC
Also, they haven't sold a share in over a year, have had their flagship product featured in Cosmo, twice and expect over a million in sales this year.
Profitable, $1M 2017 revs, .0001 price $HBRM
Website for acquisition http://canalytix.com/
Check "Initiatives Tab"
Greenhouse Operation Optimization
" The use of non-destructive high sensitivity instrumentation could generate hundreds of thousands of dollars to the bottom-line of large growing operations."
Greenhouse Environmental Monitoring
"We have the ability to perform advanced environmental monitoring through a range of third-party licensed advanced technology sensing instrumentation and software monitoring tools"
Chemical Compound Development
"Much of the development work completed by expert growers including plant cloning and hybridization has yielded interesting plant species with new chemical compounds and opportunities for new drugs, and commercially useful products. "
Education
"We plan to launch on-line consultation service in the coming months."
Greenhouse Consulting
"Canalytix's network of experts have historically owned and managed commercial grow operations"
Private Label Products**
"To increase our margins and product offering, we have begun to create our own higher margin products, which will sell alongside nationally distributed products. " "We are currently in formulation of root stimulators and flower boosting nutrient additives. "
Home Grown Technology
"We have several provisional patents underway."
"developed scientific methods for the analysis of cannabinoids"
From the last Q
Overview
During fiscal 2015 we transitioned from our cloud-based telecommunications business to pursue a cloud-based business focused on the emerging cannabis industry. We purchased Canalytix LLC, which is developing a cloud-based application to monitor and control greenhouse facilities, providing real-time data on energy usage, HVAC systems, lighting and costs. On July 1, 2015, we purchased Plaid Canary Corporation (“PCC”), a special purpose consolidation company organized to acquire companies and technologies in emerging agricultural markets. On July 6, 2015, PCC acquired 60% of the membership units of Grow Big Supply LLC (“Grow Big”), which operated a retail supply store in Denver, Colorado targeted at those involved in growing cannabis.
We planned to use part of the Grow Big facility to provide laboratory testing and oil extraction services. The facility, however, was in a warehouse district and it was too difficult to maintain the cleanliness required for laboratory work. In February 2016, we were provided significant financial incentives from Grow Big’s landlord to close our Grow Big store and move it to another location. We laid off our staff at the store, except for our Chief Science Officer and Chief Operating Officer, and we moved our inventory to temporary storage while we searched for a location that would allow us to perform scientific work and sell off our remaining inventory. In November 2016, we secured a verbal agreement with a licensed grower and dispensary and we moved inventory from storage into its warehouse. When our existing inventory is sold, we do not plan to continue the sale of gardening products. We believe there is more value in providing scientific analysis and extraction services to entities that are operating under a cannabis license.
We have developed scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles through the use of available instruments. As our operations expand, we plan to assist medical marijuana specialty production facilities in order to better regulate, calculate proper dosage, and improve consistency in the product.
Management’s Discussion of Annual Report Financial Year Ending November 30, 2016
Herborium Group, Inc.
The following statements are of importance to current and potential investors regarding Herborium’s financial year ending November 30, 2016. In addition, the statement contains major objectives for the plan of operations for 2017.
Plan of Operations:
The following guidelines will direct the activities of Herborium Group, Inc. during 2017:
o The Company plans to continue increasing market share and revenue from AcnEase®, the Company’s all botanical acne treatment. To support this objective, in 2017, the Company:
? Developed relationship with a number of top influencers in USA, France, Canada, Spain and Argentina to increase global brand visibility.
? The Company developed a high quality Spanish Website and Social Media platform for AcnEase® to monetize Spanish Market opportunities.
? The Company upgraded its Mobile websites.
? The Company developed an Agreement with an Amazon Super Seller to
increase sales of AcnEase® on Amazon USA by multi-fold.
? The Company is preparing a deployment of AcnEase® on the Amazon
International Marketplace in Europe. The potential of this market
represents over 85 million.
? The Company initiated a number of efforts to increase wholesale
distribution of AcnEase®, one of the focal points of marketing efforts in
2017.
o The Company is pursuing a number of venues to monetize the sexual Botanical Therapeutics.
o The Company identified and secured the product extension and product line extension opportunities for 2017.
The Achievements in 2016:
• Herborium’s revenue increased 18.3 % (by approximately $130,000) to approximately $843,000 in sales, in comparison to 2015.
• The Company's gross profit increased to $530,000 in 2016, approximately $75,000 more than 2015, which is a 16% increase.
• Operating income loss was eliminated and the Company went from a loss in 2015 to a slight profit in 2016.
• The Company’s net loss for 2016 was decreased by 40% (from $87,000 in 2015 to $54,000 in 2016.)
• The Company's Acne blog was ranked one of "The Best Skincare Blogs of 2016" by Healthline for the SECOND COSECUTIVE YEAR.
• AcnEase® Facebook reached close to 67,000 likes.
• AcnEase® was featured TWICE as a unique acne treatment and beauty pick in
Cosmopolitan Magazine in France.
Outlook for 2017:
Herborium remains very optimistic about growing its business, sales and product awareness due to the steady growth of the AcnEase® brand in the US and abroad, as well as new products entering the market in 2017. This is the first year that Herborium has achieved a positive operating income. The Company continues its efforts to increase market penetration in both retail and wholesale sectors with the latest steadily gaining a more prominent role in the Company’s growth. The Company also continues to decrease costs and retire debt. The Company is still recognizing the expenses associated with developing and preparing the launch of new products. Herborium will continue its growth and its search for partners and creative financing opportunities to support this growth.
In 2016, the global nutraceutical market was valued at about $250 billion and it is expected to reach around $385 billion by the year 2021. The United States nutraceutical market dominates this growth, accounting for approximately 36%.
/s/ Dr. Agnes P. Olszewski _________________________
Dr. Agnes Olszewski President & CEO
Annual Report out March 2....all fillings on otcmarkets.com (link to Annual below)
http://www.otcmarkets.com/financialReportViewer?symbol=HBRM&id=167195
S1 is out. They are raising capital for FDA trials. Looking good here
HBRM's acnease was featured in Cosmopolitan magazine twice. It was a top pick by the editor. Acnease is all over the Internet and HBRM has one of the top acne blogs in the world.
This company has had a quiet period but will be surpassing a million in sales this year and that is anything but quiet.
MMs been silently covering their shorts. This stock is way overdue. Find me one PROFITABLE stock on the OTC with such a steal of a stock price.....other than HBRM........you can't!!!
Hike up your skirt, grab your cajonnes and lets make some money
Read the Ibox. A/s was for potential acquisitions. And r/s rumors were addressed. Company has no intention to r/s.
A/s was increased for potential acquisitions. So far no acquisitions and therefore the o/s has remained constant for over a year now. It's all in the PRs. They even PR'd saying no r/s so they care about shareholders (not to mention they took shares over salaries) and so this stock can only go up.
IBOX has EVERYTHING.
Cherry Picking:
Acnease, the flagship product:
Herbal acne prevention product. NOT a topical symptom treating solution such as proactive. Acnease is designed to stop future outbreaks before they occur. Comparable products in the acne prevention category are Acutane and birth control pills. While Acutane is 90% effective there are severe adverse side effects and there are plenty of lawsuit commercials on TV attempting to represent those affected. People who take Acutane regularly go through blood testing to monitor liver enzyme levels and if levels are too high they must stop Accutane or face liver disease. On the other hand, Acnease is 96% effective and completely natural and therefore has no side effects; Acnease is head and shoulders above the competition.
2016 was first profitable year for the company (done w/o selling a single share)
HBRM made a big push in international markets in 2016 especially in France and UK where sales DOUBLED.
2016 Herborium's Revenue increased by 18.3 %
2016 Gross Profit increased by 16.3%
The Company's Acne blog was ranked on "The Best Skincare Blogs of 2016" by Healthline for the SECOND CONSECUTIVE YEAR.
Featured in Cosmopolitan Magazine twice as a top beauty editor pick for acne treatment
2017 expectation of over a million in sales to HUT Group
2017 expectation of expanded product pipeline and increased market penetration in both retail and wholesale sectors.
All in all, HBRM is PROFITABLE, POPULAR and EXPANDING.
The pps as of now, is par value and can only go up. The company has NOT SOLD A SHARE IN OVER A YEAR. Everything is coming together quickly for this company and its current shareholders.
2017 will be BIG
2016 was the first profitable year for this company. 2017 will see over a million in sales from the HUT Group alone. Also, looking into the annual report I found this gem. The CEO Agnes accepted 1.5M shares for 600k worth of debt from deferred salaries. The scientific adviser accepted 1 M shares for $570k worth of deferred salaries. The top management is willing to sacrifice their personal income in the short term because they know they will make more money in the long-term. 2017 will be big for this company, easy run over a penny here. IMO we see a nickel.
Herborium Group Inc, Shareholder Update Letter
Fort Lee, NJ -- (ReleaseWire) -- 01/05/2017 -- Herborium® Group, Inc. (OTCPink:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) targeting dermatological issues such as acne and rosacea, and other health and wellness concerns, is happy to provide this Shareholders Update Letter from Dr. Agnes P. Olszewski the CEO.
To Our Valued Shareholders,
Happy New Year!
By now the last pie has been eaten and the last gift unpacked so it's time to provide an update on the recent milestones we achieved in 2016 and discuss our opportunities and our vision for 2017 and the Company's future.
As the first step we would like to highlight several recent business activities since the last year was full of milestones for Herborium Group.
We achieved substantial progress implementing strategies to increase sales, strengthen our brand recognition and reactivate efforts to create and capture shareholders value. Every quarter in 2017 our sales grew by double digits. Pivotal sales events including Black Friday and Cyber Monday showed sales of our leading product, AcnEase®, increased 105% over the same sales events in 2015.
Revenues & Sales Growth
We are pursuing number of growth initiatives while capitalizing on diverse opportunities in the United States and overseas. Thanks to our global strategy we have been able to provide viable solutions for all types of acne and other growing skin problems on almost EVERY continent. From Europe to the Caribbean's, from the skyscrapers of New York to bustling towns of Asia, from historical South America to the colorful cities of Africa our unique acne treatment AcnEase® has helped thousands of women and men of every age and skin tone achieve healthy skin, and a healthy self–perception. This global outreach resulted in 18% sales growth in comparison to the previous year. We have accomplished this without sacrificing our healthy margin.
Over 75 million people have acne in the USA alone;120 million I Europe. Seventy five percent of all individuals will suffer from acne at some point in their lives. The acne treatment and prevention market is steadily growing while at the same time no new products are emerging and the number of previously used treatments is dwindling or restricted because of recognized health concerns (Accutane, antibiotics, oral contraceptives as examples). The average age of the acne sufferer has increased during the past decade from 21 years old to 26 years old, making adult acne an burgeoning epidemic.
AcnEase® is a systemic, proprietary all herbal product that contains no chemicals, no gluten, animal by products or phytoestrogens and has demonstrated up to 96% efficacy in eliminating and preventing acne breakouts with no adverse side effects. From a regulatory perspective, AcnEase is considered a nutraceutical allowing AcnEase to take advantage of the rapid global growth of the nutraceutical market. For instance, the global nutraceutical market is valued at around USD 250 billion in 2016 and is expected to reach around USD 385 billion by 2021, at a CAGR of 7.5% from 2016 to 2021. The US nutraceutical market has dominated this growth accounting for ~ 36% of this growth.
We made a big push in international markets in 2016 especially in France and UK where our sales doubled. We developed new, promising distribution partnerships in these markets and revitalized old once. We expect this strengthen distribution infrastructure to support further sales growth in 2017.
New Mobile Websites and Social Media Presence
6 months ago we deployed new, state of the art mobile websites for English, French and Spanish markets and expect these platforms to support further sales growth. Deployment of the Spanish language website and formulation of the Spanish language market strategy has been especially important as Hispanic beauty and wellness market is the FASTEST growing sector in the USA and globally with 97% of Hispanic households are buying products in this category with 8% growth in spending annually. By the end of 2016 we have established relationships with two powerful social medial influencers in the Spanish market and we expect this market to become a strong driver for our 2017 revenues.
In 2016 we made a real splash in media both in the USA and abroad. We were chosen by Cosmopolitan Magazine (one of the most prominent women's publication in the world) as a top beauty editor pick for acne treatment; we won the Top Acne and Skincare Blog by Healthline for the second year in a row; AcnEase has been featured on ABC and CBS TV shows in such important geodemographically areas as the San Francisco Bay Area and Seattle, AcnEase has also been picked up by a number of prominent influencers with hundreds of thousands of followers in the US and overseas.
New Opportunities
Last but not least, it is important to note that in 2016 the Company developed a strategy for product line extension in skincare sector and for commercializing its unique Botanical Therapeutics® in the highly demanded sectors of women and men's sexual health and energy replenishment. In 2017 Herborium will focus on adding a complementary skincare product to AcnEase line and on pursuing licensing and direct commercial opportunities for the sexual health and energy formulations that combined represent over $50 billion market potential.
Capital Structure
All 2016 milestones and progress have been achieved without increasing the number of outstanding shares and without any changes in the Company's capital structure.
In summary, 2016 marked a significant progress and established a solid foundation for the future growth of the Company and increase in shareholders value.
We are looking forward with confidence to a great 2017 and we are committed to share all the important developments with our shareholders. With a growing global demand for natural wellness and beauty products, and natural medicinal products Herborium's unique Botanical Therapeutics® provide both an opportunity for the Company and a valuable solution for global challenges and evolving consumer and healthcare sector needs. With the growing demand for its signature acne product, new products ready for commercialization and a near term pipeline supported by o its unique expertise, Herborium Group is in an ideal position to take advantage of emerging nutraceutical market trends and to meet more demanding consumer, manufacturing and regulatory standards for the industry.
Sincerely,
Dr. Agnes P. Olszewski CEO & Chairwoman
As a mod can you sticky the posts of the recent news or make me a mod. I'd like to update the board and put new info on the page.
Last quarterly was in October expect next this month.
http://www.otcmarkets.com/stock/HBRM/filings